Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American Medical Directors Association"
DOI: 10.1016/j.jamda.2017.02.009
Abstract: OBJECTIVE To investigate whether polypharmacy is associated with a higher incidence of frailty in a large cohort of North Americans during 8 years of follow-up. DESIGN Longitudinal study, follow-up of 8 years. PARTICIPANTS A total of 4402… read more here.
Keywords: risk; polypharmacy associated; study; associated higher ... See more keywords
Is polypharmacy associated with mortality in the very old: Findings from the Newcastle 85+ Study
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15211
Abstract: Polypharmacy is common in the very old (≥85 years), where little is known about its association with mortality. We aimed to investigate the association between polypharmacy and all‐cause mortality in the very old, over an 11‐year… read more here.
Keywords: polypharmacy; polypharmacy associated; newcastle study; mortality ... See more keywords
SAT0099 Polypharmacy is associated with an increased risk of adverse outcomes in patients with rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.2262
Abstract: Background In the general population, polypharmacy (PP) is associated with increased risk of adverse events. The relationship between adverse outcomes and PP in Rheumatoid Arthritis (RA) has not been studied in depth. The mantra of… read more here.
Keywords: polypharmacy associated; adverse outcomes; relationship; associated increased ... See more keywords